Home › Germ Cell and Embryonal Cancer › Ohio › Columbus
Germ Cell and Embryonal Cancer clinical trials in Columbus, OH
5 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
RecruitingPhase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RecruitingPhase 3
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- and 15 more
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
- The Ohio State University, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RecruitingPhase 1/2
- Nationwide Children's Hospital, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Germ Cell and Embryonal Cancer trials in other cities
- Houston, TX6 studies
- New York City, NY5 studies
- St. Louis, MO4 studies
- Indianapolis, IN4 studies
- Chicago, IL4 studies
- Memphis, TN3 studies
- Winston-Salem, NC3 studies
- Greenburgh, NY3 studies
- Boston, MA3 studies
- Dallas, TX3 studies
- Minneapolis, MN3 studies
- San Antonio, TX3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.